CCR presentations at AACR 2021 - Session I


The AACR Virtual Annual Meeting Session I will take place April 10-15. Please visit https://www.abstractsonline.com/pp8/#!/9325 for more information. The Virtual Annual Meeting Session II takes place May 17-21. Please check back for information on Session II talks.

A number of CCR scientists will present their research at the AACR Annual Meeting. Selected oral presentations are listed below. 
 

Friday, April 9, 2021

Time Where to View Title Presenter/Authors Session
12:05 AM - 12:05 AM On Demand From oxygen sensing to nutrient and energy sensing: Targeting the genetic basis of renal cell carcinoma Marston Linehan, M.D.,
Urologic Oncology Branch
Session SS06.OD - AACR-ASCO Joint Session: Targets in the Treatment of Renal Cell Cancer
12:05 AM - 11:59 PM On Demand How nonalcoholic fatty liver disease affects antitumor immunity in HCC Tim F. Greten, M.D.,
Thoracic and GI Malignancies Branch
Session AOS07.OD - Emerging Concepts in Liver Cancer Research
12:05 AM - 11:59 PM On Demand Understanding tumor cell clonality and Its evolution by single-cell transcriptomics in liver cancer Xin Wei Wang, Ph.D.,
Laboratory of Human Carcinogenesis
Session AOS07.OD - Emerging Concepts in Liver Cancer Research
12:05 AM - 11:59 PM On Demand Tumor in the crossfire: Targeting PD-L1 and TGF-β with bintrafusp alfa James L. Gulley, M.D., Ph.D., Genitourinary Malignancies Branch Session SY19.OD - When Is Transforming Growth Factor Beta Targetable?
12:05 AM - 11:59 PM On Demand Near-infrared photoimmunotherapy for cancers: A new theranostic technology Hisataka Kobayashi, M.D., Ph.D., Molecular Imaging Branch Session ADT05.OD - Hybrid Technologies for Cancer Imaging, Theranostics, and Image-Guided Interventions

 

Saturday, April 10, 2021

Time Where to View Title Presenter/Authors Session
4:05 PM - 4:15 PM Channel 03 Single cell mapping of tumor infiltrating lymphocytes enables neoantigen-reactive T cell identification in metastatic human cancer Frank J. Lowery III, Ph.D.,
Surgery Branch
Session MS.TB06.01 - Redefining the Tumor Microenvironmental Vulnerability with Single Cell Technologies
4:05 PM - 4:15 PM Channel 04 The recently approved high-TMB criteria may introduce a sex bias in response to PD1 inhibitors Neelam Sinha, MSc.,
Cancer Data Science Laboratory
Session MS.EP01.01 - Identifying Disparities and Underserved Populations to Influence Personalized Medicine
5:20 PM - 5:30 PM Channel 04 High urinary thromboxane B2 associates with lethal prostate cancer in African American men and inversely correlates with aspirin use Maeve Bailey-Whyte, Ph.D., Laboratory of Human Carcinogenesis Session MS.EP01.01 - Identifying Disparities and Underserved Populations to Influence Personalized Medicine
5:20 PM - 5:30 PM Channel 05 Immune cell transcriptomic signatures in different cancer types markedly diverge from their corresponding signatures in the peripheral blood Fiorella Schischlik, Ph.D.,
Cancer Data Science Laboratory
Session MS.BSB02.01 - Integrative Data Analysis and Systems Modeling


Sunday, April 11, 2021

Time Where to View Title Presenter/Authors Session
2:50 PM - 3:00 PM Channel 06 Identification of first-in-class KDM3B inhibitors that suppress PAX3-FOXO1 oncogene activity in fusion positive rhabdomyosarcoma Yong Yean Kim, M.D., Ph.D.,
Genetics Branch
Session MS.ET06.01 - New Therapeutics Targeting Molecular Drivers in Cancer
3:05 PM - 3:15 PM Channel 03 Activating mucosal-associated invariant T cells (MAITs) induces a broad anti-tumor response and offers a novel target for cancer immunotherapy Benjamin Ruf, M.D.,
Thoracic and GI Malignancies Branch
Session MS.IM01.01 - Mapping the Cellular and Molecular Cues That Control Therapeutic Antitumor Immunity


Monday, April 12, 2021

Time Where to View Title Presenter/Authors Session
10:00 AM - 10:30 AM Channel 06 Panel Discussion

Tim F. Greten, M.D.,
Thoracic and GI Malignancies Branch; Panel Chair and Panelist

Xin-Wei Wang, Ph.D.,
Laboratory of Human Carcinogenesis, Panelist

AOS07.DISC - Panel-- Emerging Concepts in Liver Cancer Research

 

Tuesday, April 13, 2021

Time Where to View Title Presenter/Authors Session
2:30 PM - 3:00 PM Channel 08 Invited Speaker Dinah S. Singer, Ph.D.,
Experimental Immunology Branch
SS09 - Recent Progress and the Future of the Cancer Moonshot
2:30 PM - 3:00 PM Channel 02 Panel Discussion W. Marston Linehan, M.D.
Urologic Oncology Branch
SS06.DISC - Panel-- AACR-ASCO Joint Session: Targets in the Treatment of Renal Cell Cancer
3:30 PM - 4:00 PM Channel 03 Panel Discussion James L. Gulley, M.D., Ph.D.
Genitourinary Malignancies Branch
SY19.DISC - Panel-- When Is Transforming Growth Factor Beta Targetable?

 

Wednesday, April 14, 2021

Time Where to View Title Presenter/Authors Session
1:30 PM - 2:00 PM Channel 07 Panel Discussion Hisataka Kobayashi, M.D., Ph.D.
Molecular Imaging Branch
ADT05.DISC - Panel-- Hybrid Technologies for Cancer Imaging, Theranostics, and Image-Guided Interventions